Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 16OTHER_GOV 2INDUSTRY 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia, Myeloid, Acute 879Leukemia, Lymphocytic, Chronic, B-Cell 560Leukemia 426Hematologic Neoplasms 332Precursor Cell Lymphoblastic Leukemia-Lymphoma 331Myelodysplastic Syndromes 302Leukemia, Myelogenous, Chronic, BCR-ABL Positive 244Lymphoma, Non-Hodgkin 224Recurrence 222Lymphoma 196Neoplasms 195Multiple Myeloma 129Lymphoma, Mantle-Cell 119Lymphoma, Large B-Cell, Diffuse 114Lymphoma, Follicular 114Leukemia, Myelomonocytic, Chronic 89Lymphoma, B-Cell 88Lymphoma, B-Cell, Marginal Zone 85Leukemia, B-Cell 79Burkitt Lymphoma 64Leukemia, Myeloid, Chronic-Phase 57Waldenstrom Macroglobulinemia 56Leukemia, Myeloid 53Hodgkin Disease 47Hematologic Diseases 47Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 45Myeloproliferative Disorders 40Primary Myelofibrosis 39Bronchiolitis Obliterans Syndrome 35Anemia, Refractory, with Excess of Blasts 32

Interventions

isavuconazole 1Voriconazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Invasive Fungal Infections × Other hematologic neoplasm × Clear all
NCT03241550 2024-11-19

A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients

Astellas Pharma Inc

Phase 1 Completed
49 enrolled
Other hematologic neoplasm

Invasive Fungal Infections, Hematologic Neoplasms

NCT00143312 2009-10-06

VOSIFI

Pfizer

Phase 4 Completed
45 enrolled 15 charts
Other hematologic neoplasm

Invasive Fungal Infections, Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡